| Product Code: ETC7537903 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Axial Spondyloarthritis (axSpA) Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, 2021 & 2031F |
3.3 India Axial Spondyloarthritis (axSpA) Market - Industry Life Cycle |
3.4 India Axial Spondyloarthritis (axSpA) Market - Porter's Five Forces |
3.5 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
4 India Axial Spondyloarthritis (axSpA) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of axial spondyloarthritis (axspa) in India |
4.2.2 Growing investments in healthcare infrastructure and research for axspa treatment in India |
4.2.3 Rising prevalence of axspa among the Indian population, especially in younger age groups |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for axspa treatment in India |
4.3.2 High cost of biologic therapies and other advanced treatments for axspa in India |
4.3.3 Lack of standardized treatment guidelines and variability in healthcare practices across different regions in India |
5 India Axial Spondyloarthritis (axSpA) Market Trends |
6 India Axial Spondyloarthritis (axSpA) Market, By Types |
6.1 India Axial Spondyloarthritis (axSpA) Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, By Ankylosing spondylitis (AS), 2021- 2031F |
6.1.4 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, By Non-radiographic axial spondyloarthritis (nr-axSpA), 2021- 2031F |
6.2 India Axial Spondyloarthritis (axSpA) Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, By Non-steroidal anti-inflammatory drugs (NSAID), 2021- 2031F |
6.2.3 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.2.4 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, By Anti-rheumatic drugs, 2021- 2031F |
6.2.5 India Axial Spondyloarthritis (axSpA) Market Revenues & Volume, By Others, 2021- 2031F |
7 India Axial Spondyloarthritis (axSpA) Market Import-Export Trade Statistics |
7.1 India Axial Spondyloarthritis (axSpA) Market Export to Major Countries |
7.2 India Axial Spondyloarthritis (axSpA) Market Imports from Major Countries |
8 India Axial Spondyloarthritis (axSpA) Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of axspa in India |
8.2 Number of clinical trials and research studies conducted on axspa treatments in India |
8.3 Patient adherence rate to axspa treatment regimens in India |
9 India Axial Spondyloarthritis (axSpA) Market - Opportunity Assessment |
9.1 India Axial Spondyloarthritis (axSpA) Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 India Axial Spondyloarthritis (axSpA) Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10 India Axial Spondyloarthritis (axSpA) Market - Competitive Landscape |
10.1 India Axial Spondyloarthritis (axSpA) Market Revenue Share, By Companies, 2024 |
10.2 India Axial Spondyloarthritis (axSpA) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here